162 related articles for article (PubMed ID: 2878723)
1. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
[TBL] [Abstract][Full Text] [Related]
2. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
Cobbe SM; Manley BS
Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
[TBL] [Abstract][Full Text] [Related]
3. Class III action of beta-blocking agents.
Taggart P; Donaldson R; Abed J; Nashat F
Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
[TBL] [Abstract][Full Text] [Related]
4. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
[TBL] [Abstract][Full Text] [Related]
6. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
Gomoll AW; Bartek MJ
Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
[TBL] [Abstract][Full Text] [Related]
8. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.
Hicks MN; Cobbe SM
Cardiovasc Res; 1990 May; 24(5):404-10. PubMed ID: 2372795
[TBL] [Abstract][Full Text] [Related]
10. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
Salimi M
Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
Shimotori M; Kobayashi M; Chiba S
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
[TBL] [Abstract][Full Text] [Related]
12. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
Nakaya H; Kimura S; Nakao Y; Kanno M
Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic effect of beta-adrenoceptor-blocking drugs in Purkinje fibres of guinea-pig hearts.
Lemmens-Gruber R; Zilberszac A; Heistracher P
Arch Int Pharmacodyn Ther; 1996; 331(1):46-58. PubMed ID: 8896710
[TBL] [Abstract][Full Text] [Related]
14. Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.
Ban T; Sada S; Takahashi Y; Sada H; Fujita T
Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):77-85. PubMed ID: 2582279
[TBL] [Abstract][Full Text] [Related]
15. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
16. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
Sen L; Cui G; Sakaguchi Y; Singh BN
J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
[TBL] [Abstract][Full Text] [Related]
17. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
Doggrell SA
Chirality; 1993; 5(1):8-14. PubMed ID: 8095397
[TBL] [Abstract][Full Text] [Related]
18. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
[TBL] [Abstract][Full Text] [Related]
19. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
Harry JD; Linden RJ; Snow HM
Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
[TBL] [Abstract][Full Text] [Related]
20. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
